Docs Still in Dark on Anticoagulant Choice in Severe Kidney Disease Docs Still in Dark on Anticoagulant Choice in Severe Kidney Disease

Although NOACs offer"similar or greater benefit" over warfarin-like drugs in early chronic kidney disease, lack of evidence in severe disease makes anticoagulant choice a judgment call, say experts.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Nephrology News Source Type: news